U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: November 25 - December 1, 2018
  1. FDA Meetings, Conferences and Workshops

Public Calendar: November 25 - December 1, 2018

Public Calendar: November 25 - December 1, 2018

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 11/27/2018
Location: Washington, DC
Subject: Duke-Margolis Center for Health Policy: Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Industry, government, media, and other registered guests

Event Date: 11/28/2018
Location: Silver Spring, MD
Subject: FDA Office of Criminal Investigations: Pharmaceutical Industry Day
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Industry and government

Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 11/30/2018
Location: Washington, DC
Subject: Bloomberg American Health Summit 2018
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 11/29/2018
Location: Washington, DC
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: MICHAEL MURPHY; WILLIAM FLYNN; ASHLEY STEEL; CINDY BURNSTEEL; SUSAN BRIGHT-PONTE;
Non FDA Participant/Group: Several members from the Animal Agriculture Coalition

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 11/27/2018
Location: Jefferson, Arkansas
Subject: Arkansas Research Alliance: National Center for Toxicological Research: Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Arkansas Research Alliance Organization

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event